Anika Therapeutics (ANIK) Exchange Rate Effect (2010 - 2026)
Anika Therapeutics' (ANIK) quarterly Exchange Rate Effect came in at -$29000.0 in Q1 2026, down 126.85% year-on-year from $108000.0 in Q1 2025, and up 55.38% on a QoQ basis from -$65000.0 in Q4 2025.
Anika Therapeutics (ANIK) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Exchange Rate Effect data on file, last reported at -$29000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 126.85% year-over-year to -$29000.0 in Q1 2026; TTM through Mar 2026 was -$51000.0, a 156.04% decrease from a year earlier, with the FY2025 full-year figure at $86000.0, up 279.17% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$29000.0, up from -$65000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for ANIK reached as high as $345000.0 in Q2 2025 and fell as low as -$302000.0 in Q3 2025.
- Historically, Exchange Rate Effect has averaged -$2470.6 across 5 years, with a median of -$29000.0 in 2026.
- Across the five-year window, Exchange Rate Effect jumped 850.0% in 2023 and plunged 929.63% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at -$69000.0 in 2022, then jumped by 210.14% to $76000.0 in 2023, then slumped by 271.05% to -$130000.0 in 2024, then soared by 50.0% to -$65000.0 in 2025, then surged by 55.38% to -$29000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$29000.0 in Q1 2026, -$65000.0 in Q4 2025, and -$302000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Anika Therapeutics | 198.50 Mn | 131.71 Mn | 19.00 Mn | -29,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29,000.00 |
| Mar 31, 2026 | -29,000.00 |
| Dec 31, 2025 | -65,000.00 |
| Dec 31, 2025 | -65,000.00 |
| Sep 30, 2025 | -302,000.00 |
| Sep 30, 2025 | -302,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Dec 31, 2024 | -130,000.00 |
| Dec 31, 2024 | -130,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Jun 30, 2024 | -224,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Dec 31, 2023 | 76,000.00 |